Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-13

Clinical Trial Results: Intranasal Insulin for Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal insulin for posttraumatic stress disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal insulin (insulin)

Snippet

Sponsor: VA Connecticut Healthcare System | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2026-07-13